114 related articles for article (PubMed ID: 38654356)
1. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling.
Zhu Z; Wang H; Qian X; Xue M; Sun A; Yin Y; Tang J; Zhang J
Clin Breast Cancer; 2024 Jun; 24(4):e244-e257.e1. PubMed ID: 38378361
[TBL] [Abstract][Full Text] [Related]
2. COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk.
Chen X; Ma C; Li Y; Liang Y; Chen T; Han D; Luo D; Zhang N; Zhao W; Wang L; Yang Q
Oncogene; 2024 Jun; 43(23):1742-1756. PubMed ID: 38609499
[TBL] [Abstract][Full Text] [Related]
3. HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer.
Ramos Solis N; Cannon A; Dilday T; Abt M; Oblak AL; Soloff AC; Kaplan MH; Yeh ES
Oncoimmunology; 2024; 13(1):2364382. PubMed ID: 38846083
[TBL] [Abstract][Full Text] [Related]
4. CXCL1/IGHG1 signaling enhances crosstalk between tumor cells and tumor-associated macrophages to promote MC-LR-induced colorectal cancer progression.
Wang L; Chen W; Jin H; Tan Y; Guo C; Fu W; Wu Z; Cui K; Wang Y; Qiu Z; Zhang G; Liu W; Zhou Z
Environ Pollut; 2024 Jun; 351():124081. PubMed ID: 38697251
[TBL] [Abstract][Full Text] [Related]
5. Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer.
Sceneay J; Goreczny GJ; Wilson K; Morrow S; DeCristo MJ; Ubellacker JM; Qin Y; Laszewski T; Stover DG; Barrera V; Hutchinson JN; Freedman RA; Mittendorf EA; McAllister SS
Cancer Discov; 2019 Sep; 9(9):1208-1227. PubMed ID: 31217296
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer.
Singh S; Lee N; Pedroza DA; Bado IL; Hamor C; Zhang L; Aguirre S; Hu J; Shen Y; Xu Y; Gao Y; Zhao N; Chen SH; Wan YW; Liu Z; Chang JT; Hollern D; Perou CM; Zhang XHF; Rosen JM
Cancer Res; 2022 Jun; 82(12):2281-2297. PubMed ID: 35442423
[TBL] [Abstract][Full Text] [Related]
7. ACSL4-Mediated Membrane Phospholipid Remodeling Induces Integrin β1 Activation to Facilitate Triple-Negative Breast Cancer Metastasis.
Qiu Y; Wang X; Sun Y; Jin T; Tang R; Zhou X; Xu M; Gan Y; Wang R; Luo H; Liu M; Tang X
Cancer Res; 2024 Jun; 84(11):1856-1871. PubMed ID: 38471082
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.
Chen J; Feng W; Sun M; Huang W; Wang G; Chen X; Yin Y; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
Gastroenterology; 2024 Feb; ():. PubMed ID: 38417530
[TBL] [Abstract][Full Text] [Related]
9. SLC7A2-Mediated Lysine Catabolism Inhibits Immunosuppression in Triple Negative Breast Cancer.
Sun Y; Li Y; Jiang C; Liu C; Song Y
Crit Rev Eukaryot Gene Expr; 2024; 34(5):31-43. PubMed ID: 38842202
[TBL] [Abstract][Full Text] [Related]
10. Eliciting the antitumor immune response with a conditionally activated PD-L1 targeting antibody analyzed with a quantitative systems pharmacology model.
Ippolito A; Wang H; Zhang Y; Vakil V; Bazzazi H; Popel AS
CPT Pharmacometrics Syst Pharmacol; 2024 Jan; 13(1):93-105. PubMed ID: 38058278
[TBL] [Abstract][Full Text] [Related]
11. Modulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial.
Guo L; Hong SC; Wang X; Wang SQ; Wang N; Wei XQ; Situ HL; Wang ZY
Breast Cancer (Dove Med Press); 2024; 16():289-303. PubMed ID: 38835647
[TBL] [Abstract][Full Text] [Related]
12. Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer.
Takchi A; Zhang M; Jalalirad M; Ferre RL; Shrestha R; Haddad T; Sarkaria J; Tuma A; Carter J; David H; Giridhar K; Wang L; Lange C; Lendahl U; Ingle J; Goetz M; D'Assoro AB
Front Oncol; 2024; 14():1384277. PubMed ID: 38873259
[TBL] [Abstract][Full Text] [Related]
13. The Voices of the Dead.
Lingis A
J Bioeth Inq; 2023 Dec; 20(4):631-632. PubMed ID: 37679661
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.
Wang S; Li J; Hong S; Wang N; Xu S; Yang B; Zheng Y; Zhang J; Pan B; Hu Y; Wang Z
J Exp Clin Cancer Res; 2024 Apr; 43(1):121. PubMed ID: 38654356
[TBL] [Abstract][Full Text] [Related]
15. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
16. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
[TBL] [Abstract][Full Text] [Related]
17. Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1.
Lee CH; Bae JH; Choe EJ; Park JM; Park SS; Cho HJ; Song BJ; Baek MC
Theranostics; 2022; 12(5):1971-1987. PubMed ID: 35265193
[TBL] [Abstract][Full Text] [Related]
18. Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents.
Santoni M; Romagnoli E; Saladino T; Foghini L; Guarino S; Capponi M; Giannini M; Cognigni PD; Ferrara G; Battelli N
Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):78-84. PubMed ID: 29126881
[TBL] [Abstract][Full Text] [Related]
19. Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here.
Kwa MJ; Adams S
Cancer; 2018 May; 124(10):2086-2103. PubMed ID: 29424936
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
